Literature DB >> 8140652

Adenosine A3 receptors in mast cells.

M A Beaven, V Ramkumar, H Ali.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8140652     DOI： 10.1016/0165-6147(94)90124-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  16 in total

1.  Exploring human adenosine A3 receptor complementarity and activity for adenosine analogues modified in the ribose and purine moiety.

Authors:  Philippe Van Rompaey; Kenneth A Jacobson; Ariel S Gross; Zhan-Guo Gao; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2005-02-15       Impact factor: 3.641

2.  A3-adenosine receptors: design of selective ligands and therapeutic prospects.

Authors:  Kenneth A Jacobson; Hea O Kim; Suhaib M Siddiqi; Mark E Olah; Gary L Stiles; Dag K J E von Lubitz
Journal:  Drugs Future       Date:  1995-07       Impact factor: 0.148

3.  Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.

Authors:  Y Kohno; X Ji; S D Mawhorter; M Koshiba; K A Jacobson
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

4.  Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors.

Authors:  M E Olah; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

5.  A3 Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.

Authors:  Kenneth A Jacobson; Stefano Moro; Yong-Chul Kim; An-Hu Li
Journal:  Drug Dev Res       Date:  1999-03-01       Impact factor: 4.360

6.  Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptors.

Authors:  A H Li; L Chang; X d Ji; N Melman; K A Jacobson
Journal:  Bioconjug Chem       Date:  1999 Jul-Aug       Impact factor: 4.774

7.  Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.

Authors:  A H Li; S Moro; N Melman; X D Ji; K A Jacobson
Journal:  J Med Chem       Date:  1998-08-13       Impact factor: 7.446

8.  Pyran Template Approach to the Design of Novel A3 Adenosine Receptor Antagonists.

Authors:  An-Hu Li; Xiao-Duo Ji; Hak Sung Kim; Neli Melman; Kenneth A Jacobson
Journal:  Drug Dev Res       Date:  2000-02-11       Impact factor: 4.360

9.  A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS.

Authors:  Suhaib M Siddiqi; Xiao-Duo Ji; Neli Melman; Mark E Olah; Rahul Jain; Patricia Evans; Marc Glashofer; William L Padgett; Louis A Cohen; John W Daly; Gary L Stiles; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides       Date:  1996

10.  Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.

Authors:  I Feoktistov; I Biaggioni
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.